Morphologic and functional scoring of cystic fibrosis lung disease using MRI
Creators
- 1. Department of Radiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg (Germany)
- 2. Department of Biostatistics, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg (Germany)
- 3. Department of Diagnostic Radiology, University Hospital Schleswig-Holstein, Campus Kiel, Arnold-Heller-Str. 3, 24105 Kiel (Germany)
- 4. Division of Pediatric Pulmonology and Cystic Fibrosis Center, Department of Pediatrics III, University Hospital Heidelberg, Im Neuenheimer Feld 430, 69120 Heidelberg (Germany)
- 5. Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, Im Neuenheimer Feld 110, 69120 Heidelberg (Germany)
- 6. Department of Diagnostic and Interventional Radiology, Chest Clinics at University Hospital Heidelberg, Amalienstr. 5 69126 Heidelberg (Germany)
Description
Magnetic resonance imaging (MRI) gains increasing importance in the assessment of cystic fibrosis (CF) lung disease. The aim of this study was to develop a morpho-functional MR-scoring-system and to evaluate its intra- and inter-observer reproducibility and clinical practicability to monitor CF lung disease over a broad severity range from infancy to adulthood. 35 CF patients with broad age range (mean 15.3 years; range 0.5–42) were examined by morphological and functional MRI. Lobe based analysis was performed for parameters bronchiectasis/bronchial-wall-thickening, mucus plugging, abscesses/sacculations, consolidations, special findings and perfusion defects. The maximum global score was 72. Two experienced radiologists scored the images at two time points (interval 10 weeks). Upper and lower limits of agreement, concordance correlation coefficients (CCC), total deviation index and coverage probability were calculated for global, morphology, function, component and lobar scores. Global scores ranged from 6 to 47. Intra- and inter-reader agreement for global scores were good (CCC: 0.98 (R1), 0.94 (R2), 0.97 (R1/R2)) and were comparable between high and low scores. Our results indicate that the proposed morpho-functional MR-scoring-system is reproducible and applicable for semi-quantitative evaluation of a large spectrum of CF lung disease severity. This scoring-system can be applied for the routine assessment of CF lung disease and maybe as endpoint for clinical trials.
Availability note (English)
Available from http://dx.doi.org/10.1016/j.ejrad.2011.02.045Additional details
Identifiers
- DOI
- 10.1016/j.ejrad.2011.02.045;
- PII
- S0720-048X(11)00231-2;
Publishing Information
- Journal Title
- European Journal of Radiology
- Journal Volume
- 81
- Journal Issue
- 6
- Journal Page Range
- p. 1321-1329
- ISSN
- 0720-048X
- CODEN
- EJRADR
INIS
- Country of Publication
- Netherlands
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 43078709
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- ABSCESSES; CLINICAL TRIALS; DIGESTIVE SYSTEM DISEASES; FIBROSIS; IMAGES; LUNGS; MORPHOLOGY; NMR IMAGING; PATIENTS
- Descriptors DEC
- BODY; DIAGNOSTIC TECHNIQUES; DISEASES; ORGANS; PATHOLOGICAL CHANGES; RESPIRATORY SYSTEM; TESTING
Optional Information
- Copyright
- Copyright (c) 2011 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.